Kathleen Scott - 16 Oct 2024 Form 4 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Signature
/s/ Kathleen Scott
Issuer symbol
SPRY
Transactions as of
16 Oct 2024
Transactions value $
-$181,250
Form type
4
Filing time
17 Oct 2024, 16:30:32 UTC
Previous filing
21 Aug 2024
Next filing
10 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRY Common Stock Options Exercise $18,750 +12,500 +253% $1.5 17,449 16 Oct 2024 Direct F1
transaction SPRY Common Stock Sale -$200,000 -12,500 -72% $16 4,949 16 Oct 2024 Direct F2
holding SPRY Common Stock 8,250 16 Oct 2024 See footnote F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPRY Stock Option (Right to Buy) Options Exercise $0 -12,500 -1.5% $0 802,330 16 Oct 2024 Common Stock 12,500 $1.5 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The Reporting Person inadvertently added the holdings of Scott 2008 Trust Dated 3/28/08 (the "Trust") as directly held on her Form 4 filed on August 20, 2024. As of the date of that Form 4, the Reporting Person owned 8,250 shares indirectly through the Trust.
F2 The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024.
F3 By the Trust.
F4 Immediately exercisable.